Figure 1.

Study design. In the initial design, all participants could be randomised into the oro-dispersible tablet group. When we no longer could procure these tablets, the second design was as pictured in Figure 1. A standard design would have had 4 days for each participant testing all 4 formulations of prednisolone in the initial design and, correspondingly, 3 formulations in the second design.